Lv4
546 积分 2024-03-29 加入
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis
2小时前
已完结
Nonclinical Development of ANX005: A Humanized Anti-C1q Antibody for Treatment of Autoimmune and Neurodegenerative Diseases
10天前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
10天前
已完结
The present and future of bispecific antibodies for cancer therapy
10天前
已完结
β-Klotho promotes glycolysis and glucose-stimulated insulin secretion via GP130
12天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
14天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
14天前
已关闭
Self‐renaturing enzymes: Design of an enzyme‐chaperone chimera as a new approach to enzyme stabilization
21天前
已关闭
Self‐renaturing enzymes: Design of an enzyme‐chaperone chimera as a new approach to enzyme stabilization
21天前
已关闭
Linkers: A synergistic way for the synthesis of chimeric proteins
21天前
已完结
皖公网安备34019202002308
